Cervicovaginal self-sampling is a reliable method for determination of prevalence of human papillomavirus genotypes in women aged 20 to 30 years

Journal of Clinical Microbiology

Volumn 49, Issue 10, 2011, Pages 3519-3522

  Deleré, Yvonne ^a   Schuster, Melanie ^a   Vartazarowa, Elena ^b   Hänsel, Thomas ^a   Hagemann, Ingke ^c   Borchardt, Simone ^d   Perlitz, Heike ^e   Schneider, Achim ^b   Reiter, Sabine ^a   Kaufmann, Andreas M ^b  

^a ROBERT KOCH INSTITUTE   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Gynecological Practice Abts+partner   (Germany)

^d Gynecology/Oncology Focus Practice   (Germany)

^e NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CERVICOVAGINAL LAVAGE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENETIC VARIABILITY; GENOTYPE; HIGH RISK PATIENT; HUMAN; INFECTION RISK; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NONHUMAN; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; RELIABILITY; SAMPLING; SELF CARE; SELF CONCEPT; SELF SAMPLING; UTERINE CERVIX CYTOLOGY; VAGINAL LAVAGE; VIRUS STRAIN; VISUAL ANALOG SCALE; WART VIRUS;

ADULT; CERVIX UTERI; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; SELF-EXAMINATION; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; VAGINA; VAGINAL DOUCHING;

HUMAN PAPILLOMAVIRUS;

EID: 80053486162     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01026-11     Document Type: Article

References (21)

1. Baseman, J. G., and L. A. Koutsky. 2005. The epidemiology of human papillomavirus infections. J. Clin. Virol. 32S:S16-S24. (Pubitemid 40332585)
2. Bosch, F. X., A. Lorincz, N. Muñoz, C. J. Meijer, and K. V. Shah. 2002. The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol. 55:244-265. (Pubitemid 34293391)
3. Brink, A. A., et al. 2006. High concordance of results of testing for human papillomavirus in cervicovaginal samples collected by two methods, with comparison of a novel self-sampling device to a conventional endocervical brush. J. Clin. Microbiol. 44:2518-2523. (Pubitemid 44092421)
4. Clifford, G. M., J. S. Smith, M. Plummer, N. Muñoz, and S. Franceschi. 2003. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br. J. Cancer 88:63-73.
5. Dannecker, C., et al. 2004. Primary cervical cancer screening by self-sampling of human papillomavirus DNA in internal medicine outpatient clinics. Ann. Oncol. 15:863-869. (Pubitemid 39004340)
6. De Villiers, E.-M., C. Fauquet, T. R. Broker, H.-U. Bernard, and H. zur Hausen. 2004. Classification of papillomaviruses. Virology 324:17-27. (Pubitemid 38737395)
7. FUTURE II Study Group. 2007. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N. Engl. J. Med. 10:1915-1927.
8. Gök, M., et al. 2010. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. BMJ 340:c1040.
9. Hillemanns, P., et al. 1999. Screening for cervical neoplasia by self-assessment for human papillomavirus DNA. Lancet. 354:1970.
10. Jones, H. E., L. Altini, A. De Kock, T. Young, and J. H. Van de Wijgert. 2007. Home-based versus clinic-based self-sampling and testing for sexually transmitted infections in Gugulethu, South Africa: randomised controlled trial. Sex. Transm. Infect. 83:552-557.
11. Jones, H. E., M. A. Wiegerinck, T. E. Nieboer, B. W. Mol, and C. L. Westhoff. 2008. Women in the Netherlands prefer self-sampling with a novel lavaging device to clinician collection of specimens for cervical cancer screening. Sex. Transm. Dis. 35:916-917.
12. Kjaer, S. K., et al. 2008. Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark. Int. J. Cancer 123:1864-1870.
13. Klug, S. J., et al. 2007. Prevalence of human papillomavirus types in women screened by cytology in Germany. J. Med. Virol. 79:616-625. (Pubitemid 46564361)
14. Munoz, N., X. Castellsague, A. Berrington de Gonzalez, and L. Gissmann. 2006. Chapter 1: HPV in the etiology of human cancer. Vaccine 24(Suppl. 3):S1-S10.
15. Nobbenhuis, M. A., et al. 2002. Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women. J. Clin. Pathol. 55:435-439. (Pubitemid 34620780)
16. Paavonen, J., et al. 2009. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 374:301-314.
17. Rambout, L., L. Hopkins, B. Hutton, and D. Fergusson. 2007. Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials. CMAJ 177:469-479. (Pubitemid 47359770)
18. Schiffman, M., P. E. Castle, J. Jeronimo, A. C. Rodriguez, and S. Wacholder. 2007. Human papillomavirus and cervical cancer. Lancet 370:890-907.
19. Schmitt, M., B. Dondog, T. Waterboer, and M. Pawlita. 2008. Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers. J. Clin. Microbiol. 46:1050-1059. (Pubitemid 351380000)
20. Smith, J. S., et al. 2007. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int. J. Cancer 121:621-632. (Pubitemid 46986496)
21. Szarewski, A., et al. 2011. HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial. Br. J. Cancer 104:915-920.